Cargando…
Evaluation of Clinical Innovation: A Gray Zone in the Ethics of Modern Clinical Practice?
BACKGROUND: Various stakeholders can have differing opinions regarding ethical review when introducing new procedures with patients. OBJECTIVE: This pilot study examines the way in which Research Ethics Boards (REBs; Institutional Review Boards) and clinical biochemists (CBs; laboratory medicine spe...
Autores principales: | Patenaude, Johane, Grant, Andrew M., Xhignesse, Marianne, Leblanc, Frédéric, Courteau, Josiane |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150637/ https://www.ncbi.nlm.nih.gov/pubmed/18095040 http://dx.doi.org/10.1007/s11606-007-0410-2 |
Ejemplares similares
-
Support for the Development of Technological Innovations: Promoting Responsible Social Uses
por: Legault, Georges A., et al.
Publicado: (2017) -
The Social and Ethical Acceptability of NBICs for Purposes of Human Enhancement: Why Does the Debate Remain Mired in Impasse?
por: Béland, Jean-Pierre, et al.
Publicado: (2011) -
A biobank management model applicable to biomedical research
por: Auray-Blais, Christiane, et al.
Publicado: (2006) -
Ethical issues in innovative clinical research
por: Qiu, Yudong
Publicado: (2022) -
Clinical Outcomes and Shoulder Kinematics for the “Gray Zone” Extra-articular Scapula Fracture in 5 Patients
por: Sharma, Jyoti, et al.
Publicado: (2020)